AI assistant
DAVITA INC. — Director's Dealing 2016
May 18, 2016
30643_dirs_2016-05-17_dae5bb49-dc0b-4c55-a385-02f6b6910d74.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-05-13
Reporting Person: Rodriguez Javier (CEO-Kidney Care)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-16 | Common Stock | S | 36466 | $75.4427 | Disposed | 64264 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-13 | Stock Appreciation Rights | $75.42 | A | 124091 | Acquired | 2021-05-13 | Common Stock (124091) | Direct |
Footnotes
F1: The sale reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2015.
F2: Represents the weighted average sale price of $75.4427. The range of prices for the sale of these shares was $75.20 - $75.96, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3: The Stock Appreciation Rights were granted on 5/13/2016. 50% will vest on 5/13/2019 and the remaining 50% will vest on 5/13/2020.